PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32123095-0	2020	Cyp2c44 regulates prostaglandin synthesis, lymphangiogenesis, and metastasis in a mouse model of breast cancer.	Prostaglandins	18-31	cytochrome P450, family 2, subfamily c, polypeptide 23	Mus musculus	0-7	
32123095-1	2020	Arachidonic acid epoxides generated by cytochrome P450 (CYP) enzymes have been linked to increased tumor growth and metastasis, largely on the basis of overexpression studies and the application of exogenous epoxides.	arachidonic acid epoxides	0-25	cytochrome P450, family 21, subfamily a, polypeptide 1	Mus musculus	39-54	
32123095-1	2020	Arachidonic acid epoxides generated by cytochrome P450 (CYP) enzymes have been linked to increased tumor growth and metastasis, largely on the basis of overexpression studies and the application of exogenous epoxides.	arachidonic acid epoxides	0-25	cytochrome P450, family 21, subfamily a, polypeptide 1	Mus musculus	56-59	
32123095-1	2020	Arachidonic acid epoxides generated by cytochrome P450 (CYP) enzymes have been linked to increased tumor growth and metastasis, largely on the basis of overexpression studies and the application of exogenous epoxides.	Epoxy Compounds	17-25	cytochrome P450, family 21, subfamily a, polypeptide 1	Mus musculus	39-54	
32123095-1	2020	Arachidonic acid epoxides generated by cytochrome P450 (CYP) enzymes have been linked to increased tumor growth and metastasis, largely on the basis of overexpression studies and the application of exogenous epoxides.	Epoxy Compounds	17-25	cytochrome P450, family 21, subfamily a, polypeptide 1	Mus musculus	56-59	
32123095-6	2020	This could be accounted for by the finding that Cyp2c44 metabolized the PG precursor, PGH2 to 12(S)-hydroxyheptadeca-5Z,8E,10E-trienoic acid (12-HHT), thus effectively reducing levels of effector PGs (including PGE2).	Prostaglandins	72-74	cytochrome P450, family 2, subfamily c, polypeptide 23	Mus musculus	48-55	
32123095-6	2020	This could be accounted for by the finding that Cyp2c44 metabolized the PG precursor, PGH2 to 12(S)-hydroxyheptadeca-5Z,8E,10E-trienoic acid (12-HHT), thus effectively reducing levels of effector PGs (including PGE2).	Prostaglandin H2	86-90	cytochrome P450, family 2, subfamily c, polypeptide 23	Mus musculus	48-55	
32123095-6	2020	This could be accounted for by the finding that Cyp2c44 metabolized the PG precursor, PGH2 to 12(S)-hydroxyheptadeca-5Z,8E,10E-trienoic acid (12-HHT), thus effectively reducing levels of effector PGs (including PGE2).	12(s)-hydroxyheptadeca-5z,8e,10e-trienoic acid	94-140	cytochrome P450, family 2, subfamily c, polypeptide 23	Mus musculus	48-55	
32123095-6	2020	This could be accounted for by the finding that Cyp2c44 metabolized the PG precursor, PGH2 to 12(S)-hydroxyheptadeca-5Z,8E,10E-trienoic acid (12-HHT), thus effectively reducing levels of effector PGs (including PGE2).	12-hydroxy-5,8,10-heptadecatrienoic acid	142-148	cytochrome P450, family 2, subfamily c, polypeptide 23	Mus musculus	48-55	
32123095-6	2020	This could be accounted for by the finding that Cyp2c44 metabolized the PG precursor, PGH2 to 12(S)-hydroxyheptadeca-5Z,8E,10E-trienoic acid (12-HHT), thus effectively reducing levels of effector PGs (including PGE2).	Phosphatidylglycerols	196-199	cytochrome P450, family 2, subfamily c, polypeptide 23	Mus musculus	48-55	
32123095-6	2020	This could be accounted for by the finding that Cyp2c44 metabolized the PG precursor, PGH2 to 12(S)-hydroxyheptadeca-5Z,8E,10E-trienoic acid (12-HHT), thus effectively reducing levels of effector PGs (including PGE2).	Dinoprostone	211-215	cytochrome P450, family 2, subfamily c, polypeptide 23	Mus musculus	48-55